Stock A096530 SEEGENE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Seegene, Inc.

Equities

A096530

KR7096530001

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
21,900 KRW -1.35% Intraday chart for Seegene, Inc. +4.29% -4.37%
Mar. 14 Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 24 Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases CI

Business Summary

Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 63

Sales per Business

KRW in Million2022Weight2023Weight Delta
Molecular Diagnostics and Reagent Goods
78.4 %
690,835 80.9 % 288,029 78.4 % -58.31%
Molecular Diagnostics and Reagent Merchandise
17.9 %
152,404 17.9 % 65,723 17.9 % -56.88%
Other
3.7 %
10,322 1.2 % 13,623 3.7 % +31.97%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
54.0 %
466,842 54.7 % 198,564 54.0 % -57.47%
Europe
29.9 %
238,416 27.9 % 109,991 29.9 % -53.87%
Americas
12.6 %
128,000 15.0 % 46,403 12.6 % -63.75%
Other
3.4 %
20,303 2.4 % 12,417 3.4 % -38.84%

Managers

Managers TitleAgeSince
Jong-Yoon Chun FOU
 Founder 66 00-09-15
Ho Lee PSD
 President 65 -
Min-Chul Lee PSD
 President 70 -
Kyung-O Min PSD
 President 68 -
Jung-Yong Kim DFI
 Director of Finance/CFO 58 -
Jin-Soo Choi PSD
 President 72 -
Myung-Gun Kim IRC
 Investor Relations Contact 61 -
Jun-Seok Oh LAW
 General Counsel 59 -
Jin-Ho Kim PRN
 Corporate Officer/Principal 60 09-06-14
Dae-Yup Choi PRN
 Corporate Officer/Principal 59 05-07-03

Members of the board

Members of the board TitleAgeSince
Jong-Yoon Chun FOU
 Founder 66 00-09-15
Kyung-Jun Chun BRD
 Director/Board Member 77 -
Hong-Il Yoon BRD
 Director/Board Member 61 10-03-21
Jin-Soo Choi PSD
 President 72 -
Jung-Yong Kim DFI
 Director of Finance/CFO 58 -
Chang-Se Lee BRD
 Director/Board Member 62 20-03-25
Hyun-Chul Jung BRD
 Director/Board Member 59 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 52,225,994 30,242,565 ( 57.91 %) 6,181,935 ( 11.84 %) 57.91 %

Shareholders

NameEquities%Valuation
Jong-Yoon Chun
18.21 %
9,508,880 18.21 % 170 M ₩
SEEGENE, INC.
11.07 %
5,779,206 11.07 % 103 M ₩
Kyung-Jun Chun
3.539 %
1,848,522 3.539 % 33 M ₩
Jong-Ki Chun
2.221 %
1,160,160 2.221 % 21 M ₩
Jeong-sook An
1.416 %
739,557 1.416 % 13 M ₩
Neodin Medical Institute
0.8368 %
437,012 0.8368 % 8 M ₩
Keum-ok Cha
0.7840 %
409,456 0.7840 % 7 M ₩
Hye-young Chun
0.4883 %
255,016 0.4883 % 5 M ₩
Sol-bi Chun
0.3830 %
200,000 0.3830 % 4 M ₩
Sol-ji Chun
0.3830 %
200,000 0.3830 % 4 M ₩

Holdings

NameEquities%Valuation
SEEGENE, INC.
11.07%
 5,779,206 11.07% 103,242,279 $

Company contact information

Seegene, Inc.

Taewon Building 91 Ogeum-ro

05548, Seoul

+

http://www.seegene.com
address Seegene, Inc.(A096530)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Diagnostics & Testing

Sales per Business

Sales per region

Ratings for Seegene, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
22,200 KRW
Average target price
25,000 KRW
Spread / Average Target
+12.61%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

1st Jan change Capi.
SEEGENE, INC. Stock Seegene, Inc.
-3.06% 743M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-14.52% 11.48B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+44.03% 3.27B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-33.09% 2.2B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-18.60% 2.05B
VERACYTE, INC. Stock Veracyte, Inc.
-27.59% 1.49B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+17.10% 1.01B
CAREDX, INC Stock CareDx, Inc
-33.50% 413M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-46.94% 377M
CURIOX BIOSYSTEMS CO., LTD Stock Curiox Biosystems Co., Ltd
+27.44% 374M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. A096530 Stock
  4. Company Seegene, Inc.